Home › DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on...
 

Keywords :   


DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on...

2015-09-10 15:12:57| Logistics - Topix.net

DelMar Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today presented updated clinical data from its Phase I/II study of lead product candidate VAL-083 , in patients with refractory glioblastoma multiforme , at GBM2015 : 2 International Symposium on Clinical and Basic Investigation in Glioblastoma in Toledo, Spain. The Company's data was presented in a poster entitled, "Update on Phase I/II study of VAL-083 in patients with recurrent malignant glioma."

Tags: data updated iii phase

Category:Transportation and Logistics

Latest from this category

All news
15.11Tropical Storm Sara Forecast Advisory Number 8
15.11Tropical Storm Sara Graphics
15.11Tropical Storm Sara Forecast Discussion Number 8
15.11Tropical Storm Sara Wind Speed Probabilities Number 8
15.11Tropical Storm Sara Public Advisory Number 8
15.11Tropical Storm Sara Graphics
15.11Summary for Tropical Storm Sara (AT4/AL192024)
15.11Tropical Storm Sara Update Statement
Transportation and Logistics »
15.11
15.11 BBM 25
15.11A-49-Black Roland MIDI
15.11
15.11DVD
15.11 22 C2500SXG
15.11Estoy Aqui
15.11WAWONA6 +
More »